Stockreport

Regeneron 2026 Outlook Balanced With Dupixent Growth, Sanofi Collaboration, RBC Says [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron Pharmaceuticals' (REGN) 2026 is shaping up as a "potentially balanced year," with Dupixent [Read more]